OTCMKTS:EAPH - Easton Pharmaceuticals Stock Price, News, & Analysis

0.00 (0.00 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
Now: $0.0045
50-Day Range N/A
52-Week Range
Now: $0.0045
Volume5.01 million shs
Average Volume4.09 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Easton Pharmaceuticals Inc., a specialty pharmaceutical company, designs, develops, and markets various topically delivered drugs and therapeutic health care products. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug. The company is also developing XILIVE, an early stage cancer drug. In addition, it is involved in the medical marijuana business. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is based in Toronto, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Current SymbolOTCMKTS:EAPH



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive EAPH News and Ratings via Email

Sign-up to receive the latest news and ratings for EAPH and its competitors with MarketBeat's FREE daily newsletter.

Easton Pharmaceuticals (OTCMKTS:EAPH) Frequently Asked Questions

What is Easton Pharmaceuticals' stock symbol?

Easton Pharmaceuticals trades on the OTCMKTS under the ticker symbol "EAPH."

Has Easton Pharmaceuticals been receiving favorable news coverage?

Headlines about EAPH stock have trended somewhat negative this week, InfoTrie reports. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Easton Pharmaceuticals earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Easton Pharmaceuticals.

Who are some of Easton Pharmaceuticals' key competitors?

What other stocks do shareholders of Easton Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Easton Pharmaceuticals investors own include 22nd Century Group (XXII), Canopy Growth (CGC), Medmen Enterprises (MMNFF), Emerald Health Therapeutics (EMHTF), GreenGro Technologies (GRNH), KushCo (KSHB), mCig (MCIG), CannaRoyalty (ORHOF), Tilray (TLRY) and Aurora Cannabis (ACB).

Who are Easton Pharmaceuticals' key executives?

Easton Pharmaceuticals' management team includes the folowing people:
  • Mr. Evan Karras, CEO, Pres, Sec. & Director
  • Mr. Nunzio J. Valerie Jr., CFO & Director (Age 57)
  • Mr. Vince Demasi, COO & Director
  • Dr. Lilla Albert Ph.D., Chief Marketing and Technology Officer
  • Ms. Elena Milantoni, Director of Fin. and Admin. (Age 49)

How do I buy shares of Easton Pharmaceuticals?

Shares of EAPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Easton Pharmaceuticals' stock price today?

One share of EAPH stock can currently be purchased for approximately $0.0045.

What is Easton Pharmaceuticals' official website?

The official website for Easton Pharmaceuticals is http://www.eastonpharmaceuticalsinc.com/.

How can I contact Easton Pharmaceuticals?

The company can be reached via phone at 416-619-0291.

MarketBeat Community Rating for Easton Pharmaceuticals (OTCMKTS EAPH)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  44
MarketBeat's community ratings are surveys of what our community members think about Easton Pharmaceuticals and other stocks. Vote "Outperform" if you believe EAPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EAPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel